Merck defeats profits expectations, raises sales outlook on powerful demand for leading medicines like Keytruda - CNBC

.Merck beats incomes requirements, raises sales expectation on strong requirement for leading medications like Keytruda CNBCMerck &amp Co. (MRK United States) Trumps Income Estimates as Keytruda Sales Rise BloombergMerck Sell: Pharma Titan Posts Solid End Results, But Overview Falls Short Investor's Service DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income and sales expectations in the middle of Keytruda advantage, but gives mixed full-year overview MarketWatch.